March 21, 2022
Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule. Researchers at UC San Diego’s Scripps Institution of Oceanography found that an enzyme called SalC assembles what the team calls the salinosporamide anti-cancer “warhead.”
November 17, 2014
Researchers at University of California, San Diego School of Medicine have developed a way to chemically disguise RNAi drugs so that they are able to enter cells. Once inside, cellular machinery converts these disguised drug precursors — called siRNNs — into active RNAi drugs.
August 7, 2015
University of California, San Diego undergraduate Angela Zou has been awarded the Barry M. Goldwater Scholarship, one of the most competitive and prestigious awards in the nation. From a field of 1,206 applicants, Zou was one of 260 students to receive the scholarship, and the only recipient from UC San…
February 28, 2023
UC San Diego’s new Astrobiotechnology Hub brings together leaders in academia, biotechnology and aerospace industries under a united mission to advance stem cell science and commercialization in space.
October 27, 2014
A hinge in the RNA genome of the virus that causes hepatitis C works like a switch that can be flipped to prevent it from replicating in infected cells. Scientists have discovered that this shape is shared by several other viruses—among them one that kills cancer cells.
February 15, 2018
Four early-career scientists at UC San Diego have been recognized for their outstanding promise in the fields of physics and computational & evolutionary molecular biology as 2018 Sloan Research Fellows.
July 6, 2015
Robert She and Angela Zou, undergraduates at the University of California, San Diego, have been recognized with national scholarship awards for research and service. Both are part of UC San Diego Academic Enrichment Programs, which pairs students with faculty mentors and research opportunities in preparation for graduate school.
May 9, 2013
DARPA, the U.S. Defense Advanced Research Projects Agency, has awarded $6 million to a team of researchers to develop nanotechnology therapies for the treatment of traumatic brain injury and associated infections.
January 23, 2023
Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.
June 17, 2020
Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.
